Corcept Therapeutics Incorporated (CORT) Profit Margins
Over the twelve months to 2026-06-30, Corcept Therapeutics Incorporated (CORT) had operating margin 0.8%, net margin 6.6%, free cash flow margin 12.9%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CORTCorcept Therapeutics IncorporatedFollow CORT — free
—
Price chart with a free account
- Market cap
- 9.3B
- P/E TTM
- 204.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2009 Dec 09 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | 97.9% | 98.2% | 98.4% | 98.6% | 98.7% | 98.7% | 98.4% | 98.3% | — | |
| Operating margin | — | 35.6% | 36.4% | 36.2% | 34.0% | 28.0% | 22.2% | 20.3% | 5.9% | 0.8% | |
| Net margin | -69537.9% | 30.0% | 30.7% | 30.0% | 30.7% | 25.2% | 22.0% | 20.9% | 13.1% | 6.6% | |
| FCF margin | — | 45.9% | 44.1% | 42.6% | 45.7% | 29.8% | 26.2% | 29.1% | 18.6% | 12.9% |
USD millions · SEC XBRL
Corcept Therapeutics Incorporated — questions
- What is Corcept Therapeutics Incorporated's operating margin?
- 0.8% over the twelve months to 2026-06-30.
- What is Corcept Therapeutics Incorporated's net profit margin?
- 6.6% over the twelve months to 2026-06-30.
Every figure on this page comes from Corcept Therapeutics Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.